Physician profile
Michael Cheng
NPI 1659766475
$6,736.31
in general payments reported to CMS, 2019-2025
7 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $615 · 2023: $5,049 · 2024: $231 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,780 · Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,779.99 |
| Food and Beverage | $863.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,007.64 | 2021-2025 | Endurant Iis, Hawkone |
| Silk Road Medical, INC. | $298.58 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inspiremd Ltd | $174.42 | 2025 | Cguard Prime Carotid Stent System |
| Cvrx, INC. | $94.88 | 2025 | Barostim Neo System |
| Aurinia Pharma U.S., INC. | $85.18 | 2024 | Lupkynis |
| Bolton Medical INC | $62.07 | 2025 | Treo Abdominal Stent-Graft System |
| Shockwave Medical, INC | $13.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.